Transient up-regulation of cocaine- and amphetamine-regulated transcript peptide (CART) immunoreactivity following ethanol withdrawal in rat hypothalamus

Brain Research

Volumn 1240, Issue , 2008, Pages 119-131

  Dandekar, Manoj P ^a   Singru, Praful S ^b   Kokare, Dadasaheb M ^a   Subhedar, Nishikant K ^c  

^a RTM NAGPUR UNIVERSITY   (India)

^b TUFTS MEDICAL CENTER   (United States)

^c INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

CART; Chronic ethanol treatment; Cocaine and amphetamine regulated transcript peptide; Ethanol withdrawal; Hypothalamus; Immunocytochemistry

Indexed keywords

ALCOHOL; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; MONOCLONAL ANTIBODY;

ALCOHOL WITHDRAWAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ANXIETY; ARCUATE NUCLEUS; ARTICLE; BRAIN REGION; CONTROLLED STUDY; HYPOTHALAMUS NUCLEUS; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PATHOGENESIS; POSTERIOR HYPOTHALAMUS; PRIORITY JOURNAL; RAT; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; UPREGULATION;

ANIMALS; ETHANOL; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME; UP-REGULATION;

ANIMALIA; PISUM SATIVUM; RATTUS;

EID: 54949111638     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.09.023     Document Type: Article

References (82)

1. Adams L.D., Gong W., Vechia S.D., Hunter R.G., and Kuhar M.J. CART: from gene to function. Brain Res. 848 (1999) 137-140
2. Asakawa A., Inui A., Yuzuriha H., Nagata T., Kaga T., Ueno N., Fujino M.A., and Kasuga M. Cocaine-amphetamine-regulated transcript influences energy metabolism, anxiety and gastric emptying in mice. Horm. Metab. Res. 33 (2001) 554-558
3. Bannon A.W., Seda J., Carmouche M., Francis J.M., Jarosinski M.A., and Douglass J. Multiple behavioral effects of cocaine- and amphetamine-regulated transcript (CART) peptides in mice: CART 42-89 and CART 49-89 differ in potency and activity. J. Pharmacol. Exp. Ther. 299 (2001) 1021-1026
4. Barsh G.S., and Schwartz M.W. Genetic approaches to studying energy balance: perception and integration. Nature Rev. Genetics 3 (2002) 589-600
5. Bellinger L.L., and Bernardis L.L. The dorsomedial hypothalamic nucleus and its role in ingestive behavior and body weight regulation: lessons learned from lesioning studies. Physiol. Behav. 76 (2002) 431-442
6. Bison S., and Crews F. Alcohol withdrawal increases neuropeptide Y immunoreactivity in rat brain. Alcohol. Clin. Exp. Res. 27 (2003) 1173-1183
7. Brodie B.B., Costa E., Dlabac A., Neff N.H., and Smookler H.H. Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J. Pharmacol. Exp. Ther. 154 (1966) 493-498
8. Chaki S., Kawashima N., Suzuki Y., Shimazaki T., and Okuyama S. Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents. Eur. J. Pharmacol. 464 (2003) 49-54
9. Couceyro P.R., Koylu E.O., and Kuhar M.J. Further studies on the anatomical distribution of CART by in situ hybridisation. J. Chem. Neuroanat. 12 (1997) 229-241
10. Damaj M.I., Hunter R.G., Martin B.R., and Kuhar M.J. Intrathecal CART (55-102) enhances the spinal analgesic actions of morphine in mice. Brain Res. 1024 (2004) 146-149
11. Damaj M.I., Zheng J., Martin B.R., and Kuhar M.J. Intrathecal CART (55-102) attenuates hyperalgesia and allodynia in a mouse model of neuropathic but not inflammatory pain. Peptides 27 (2006) 2019-2023
12. Dandekar M.P., Singru P.S., Kokare D.M., Lechan R.M., Thim L., Clausen J.T., and Subhedar N.K. Importance of cocaine- and amphetamine-regulated transcript peptide (CART) in the central nucleus of amygdala in anxiogenic responses induced by ethanol withdrawal. Neuropsychopharmacology 33 (2008) 1127-1136
13. Davis M. Neurobiology of fear responses, the role of the amygdala. J. Neuropsychiatry 9 (1997) 382-402
14. Douglass J., McKinzie A.A., and Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J. Neurosci. 15 (1995) 2471-2481
15. Eskay R.L., Giraud P., Oliver C., and Brown-Stein M.J. Distribution of alpha-melanocyte-stimulating hormone in the rat brain: evidence that alpha-MSH-containing cells in the arcuate region send projections to extra-hypothalamic areas. Brain Res. 178 (1979) 55-67
16. Fekete C., and Lechan R.M. Neuroendocrine implications for the association between cocaine- and amphetamine regulated transcript (CART) and hypophysiotropic thyrotropin-releasing hormone (TRH). Peptides 27 (2006) 2012-2018
17. Friedman H.J. Assessment of physical dependence on and withdrawal from ethanol in animals. In: Rigter H., and Crabbe J.C. (Eds). Alcohol Tolerance and Dependence (1980), Elsevier/North Holland Biomedical Press 93-121
18. Funk C.K., O'Dell L.E., Crawford E.F., and Koob G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J. Neurosci. 26 (2006) 11324-11332
19. Gautvik K.M., de Lecea L., Gautvik V.T., Danielson P.E., Tranque P., Dopazo A., Bloom F.E., and Sutcliffe J.G. Overview of the most prevalent hypothalamus specific mRNAs, as identified by directional tag PCR subtraction. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 8733-8738
20. Hirani K., Khisti R.T., and Chopde C.T. Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one. Neuropharmacology 43 (2002) 1339-1350
21. Hotta M., Shibasaki T., Yamauchi N., Ohno H., Benoit R., Ling N., and Demura H. The effects of chronic central administration of corticotropin-releasing factor on food intake, body weight, and hypothalamic-pituitary-adrenocortical hormones. Life Sci. 48 (1991) 1483-1491
22. Hubert G.W., and Kuhar M.J. Cocaine administration increases the fraction of CART cells in the rat nucleus accumbens that co-immunostain for c-Fos. Neuropeptides 42 (2008) 339-343
23. Hulsey M.G., Pless C.M., and Martin R.J. ICV administration of anti-corticotropin-releasing factor antisense oligonucleotide: effects on feeding behavior and body weight. Regul. Pept. 59 (1995) 241-246
24. Hunter R.G., and Kuhar M.J. CART peptides as targets for CNS drug development. Curr. Drug Targets CNS Neurol. Disord. 2 (2003) 201-205
25. Hunter R.G., Vicentic A., Rogge G., and Kuhar M.J. The effects of cocaine on CART expression in the rat nucleus accumbens: a possible role for corticosterone. Eur. J. Pharmacol. 517 (2005) 45-50
26. Iversen L.L., and Glowinski J. Regional studies of catecholamines in the rat brain II. Rate of turnover of catecholamines in various brain regions. J. Neurochem. 13 (1966) 671-682
27. Jaworski J.N., and Jones D.C. The role of CART in the reward/reinforcing properties of psychostimulants. Peptides 27 (2006) 1993-2004
28. Jones D.C., and Kuhar M.J. Cocaine-amphetamine-regulated transcript expression in the rat nucleus accumbens is regulated by adenylyl cyclase and the cyclic adenosine 5'-monophosphate/protein kinase a second messenger system. J. Pharmacol. Exp. Ther. 317 (2006) 454-461
29. Jung S.K., Hong M.S., Suh G.J., Jin S.Y., Lee H.J., Kim B.S., Lim Y.J., Kim M.K., Park H.K., Chung J.H., and Yim S.V. Association between polymorphism in intron 1 of cocaine- and amphetamine-regulated transcript gene with alcoholism, but not with bipolar disorder and schizophrenia in Korean population. Neurosci. Lett. 365 (2004) 54-57
30. Kask A., Schioth H.B., Mutulis F., Wikberg J.E., and Rago L. Anorexigenic cocaine- and amphetamine-regulated transcript peptide intensifies fear reactions in rats. Brain Res. 857 (2000) 283-285
31. Kimmel H.L., Carroll F.I., and Kuhar M.J. Withdrawal from repeated cocaine alters dopamine transporter protein turnover in the rat striatum. J. Pharmacol. Exp. Ther. 304 (2003) 15-21
32. Kita H., and Oomura Y. An HRP study of the afferent connections to rat medial hypothalamic region. Brain Res. Bull. 8 (1982) 53-62
33. Kliethermes C.L., Cronise K., and Crabbe J.C. Home cage activity and ingestive behaviors in mice following chronic ethanol vapor inhalation. Physiol. Behav. 85 (2005) 479-488
34. Knapp D.J., Duncan G.E., Crews F.T., and Breese G.R. Induction of Fos-like proteins and ultrasonic vocalizations during ethanol withdrawal: further evidence for withdrawal-induced anxiety. Alcohol. Clin. Exp. Res. 22 (1998) 481-493
35. Kokare D.M., Chopde C.T., and Subhedar N.K. Participation of α-melanocyte stimulating hormone in ethanol-induced anxiolysis and withdrawal anxiety in rats. Neuropharmacology 50 (2006) 536-545
36. Kokare D.M., Singru P.S., Dandekar M.P., Chopde C.T., and Subhedar N.K. Involvement of alpha-melanocyte stimulating hormone (α-MSH) in differential ethanol exposure and withdrawal related depression in rat: neuroanatomical-behavioral correlates. Brain Res. 1216 (2008) 53-67
37. Koob G.F. Alcoholism: allostasis and beyond. Alcohol. Clin. Exp. Res. 27 (2003) 232-243
38. Koylu E.O., Couceyro P.R., Lambert P.D., Ling N.C., DeSouza E.B., and Kuhar M.J. Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland. J. Neuroendocrinol. 9 (1997) 823-833
39. Koylu E.O., Couceyro P.R., Lambert P.D., and Kuhar M.J. Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J. Comp. Neurol. 391 (1998) 115-132
40. Koylu E.O., Balkan B., Kuhar M.J., and Pogun S. Cocaine and amphetamine regulated transcript (CART) and the stress response. Peptides 27 (2006) 1956-1969
41. Kristensen P., Judge M.E., Thim L., Ribel U., Christjansen K.N., Wulff B.S., Clausen J.T., Jensen P.B., Madsen O.D., Vrang N., Larsen P.J., and Hastrup S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393 (1998) 72-76
42. Kuhar M.J., and Pilotte N.S. Neurochemical changes in cocaine withdrawal. Trends Pharmacol. Sci. 17 (1996) 260-264
43. Kuhar M.J., and Dall Vechia S.E. CART peptides: novel addiction and feeding-related neuropeptides. Trends Neurosci. 22 (1999) 316-320
44. Kuhar M.J., and Yoho L.L. CART peptide analysis by Western blotting. Synapse 33 (1999) 163-171
45. Kuhar M.J., Adams S., Dominguez G., Jaworski J., and Balkan B. CART peptides. Neuropeptides 36 (2002) 1-8
46. Kuhar M.J., Jaworski J.N., Hubert G.W., Philpot K.B., and Dominguez G. Cocaine- and amphetamine-regulated transcript peptides play a role in drug abuse and are potential therapeutic targets. AAPS J. 7 (2005) E259-265
47. Larsen P.J., Seier V., Fink-Jensen A., Holst J.J., Warberg J., and Vrang N. Cocaine- and amphetamine-regulated transcript is present in hypothalamic neuroendocrine neurones and is released to the hypothalamic-pituitary portal circuit. J. Neuroendocrinol. 15 (2003) 219-226
48. Luiten P.G., and Room P. Interrelations between lateral, dorsomedial and ventromedial hypothalamic nuclei in the rat. An HRP study. Brain Res. 190 (1980) 321-332
49. Ma Z., Pearson E., and Tao R. CART peptides increase 5-hydroxytryptamine in the dorsal raphe and nucleus accumbens of freely behaving rats. Neurosci. Lett. 417 (2007) 303-307
50. Merlo Pich E., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G.F., and Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15 (1995) 5439-5447
51. Miraglia del Giudice E., Santoro N., Fiumani P., Dominguez G., Kuhar M.J., and Perrone L. Adolescents carrying a missense mutation in the CART gene exhibit increased anxiety and depression. Depress. Anxiety 23 (2006) 90-92
52. Navarro M., Cubero I., Knapp D.J., Breese G.R., and Thiele T.E. Decreased immunoreactivity of the melanocortin neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) after chronic ethanol exposure in Sprague-Dawley rats. Alcohol. Clin. Exp. Res. 32 (2008) 266-276
53. O'Donohue T.L., Miller R.L., and Jacobowitz D.M. Identification, characterization and stereotaxic mapping of intraneuronal alpha-melanocyte stimulating hormone-like immunoreactive peptides in discrete regions of the rat brain. Brain Res. 176 (1979) 101-123
54. Owens M.J., and Nemeroff C.B. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. Ciba Found. Symp. 172 (1993) 296-316
55. Pandey S.C., Zhang D., Mittal N., and Nayyar D. Potential role of the gene transcription factor cyclic AMP-responsive element binding protein in ethanol withdrawal-related anxiety. J. Pharmacol. Exp. Ther. 288 (1999) 866-878
56. Pandey S.C., Roy A., and Zhang H. The decreased phosphorylation of cyclic adenosine monophosphate (cAMP) response element binding (CREB) protein in the central amygdala acts as a molecular substrate for anxiety related to ethanol withdrawal in rats. Alcohol. Clin. Exp. Res. 27 (2003) 396-409
57. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, London
58. Rainero I., De Gennaro T., Visentin G., Brunetti E., Cerrato P., Torre E., Portaleone P., and Pinessi L. Effects of chronic ethanol treatment on alpha-MSH concentrations in rat brain and pituitary. Neuropeptides 15 (1990) 139-141
59. Roy A., Mittal N., Zhang H., and Pandey S.C. Modulation of cellular expression of glucocorticoid receptor and glucocorticoid response element-DNA binding in rat brain during alcohol drinking and withdrawal. J. Pharmacol. Exp. Ther. 301 (2002) 774-784
60. Roy A., and Pandey S.C. The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcohol. Clin. Exp. Res. 26 (2002) 796-803
61. Salinas A., Wilde J.D., and Maldve R.E. Ethanol enhancement of cocaine- and amphetamine-regulated transcript mRNA and peptide expression in the nucleus accumbens. J. Neurochem. 97 (2006) 408-415
62. Sarkar S., Wittmann G., Fekete C., and Lechan R.M. Central administration of cocaine- and amphetamine-regulated transcript increases phosphorylation of cAMP response element binding protein in corticotropin-releasing hormone-producing neurons but not in prothyrotropin-releasing hormone-producing neurons in the hypothalamic paraventricular nucleus. Brain Res. 999 (2004) 181-192
63. Schuckit M.A., and Hasselbrock V. Alcohol dependence and anxiety disorders, what is the relationship?. Am. J. Psychiatry 151 (1994) 1723-1734
64. Smith Y., Kieval J., Couceyro P.R., and Kuhar M.J. CART peptide-immunoreactive neurones in the nucleus accumbens in monkeys: ultrastructural analysis, colocalization studies, and synaptic interactions with dopaminergic afferents. J. Comp. Neurol. 407 (1999) 491-511
65. Smith S.M., Vaughan J.M., Donaldson C.J., Rivier J., Li C., Chen A., and Vale W.W. Cocaine- and amphetamine-regulated transcript activates the hypothalamic pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism. Endocrinology 145 (2004) 5202-5209
66. Spanagel R., Hölter S.M., Allingham K., Landgraf R., and Zieglgänsberger W. Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur. J. Pharmacol. 305 (1996) 39-44
67. Spanagel R., Putzke J., Stefferl A., Schöbitz B., and Zieglgänsberger W. Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat. Eur. J. Pharmacol. 305 (1996) 45-50
68. Spiess J., Villarreal J., and Vale W. Isolation and sequence analysis of a somatostatin-like polypeptide from ovine hypothalamus. Biochemistry 20 (1981) 1982-1988
69. Stanek L.M. Cocaine- and amphetamine related transcript (CART) and anxiety. Peptides 27 (2006) 2005-2011
70. Thiele T.E., Navarro M., Sparta D.R., Fee J.R., Knapp D.J., and Cubero I. Alcoholism and obesity: overlapping neuropeptide pathways?. Neuropeptides 37 (2003) 321-337
71. Thiele T.E., Sparta D.R., Hayes D.M., and Fee J.R. A role for neuropeptide Y in neurobiological responses to ethanol and drugs of abuse. Neuropeptides 38 (2004) 235-243
72. Thim L., Nielsen P.F., Judge M.E., Andersen A.S., Diers I., Egel-Mitani M., and Hastrup S. Purification and characterization of a new hypothalamic satiety peptide, cocaine and amphetamine regulated transcript (CART), produced in yeast. FEBS Lett. 428 (1998) 263-268
73. Thim L., Kristensen P., Nielsen P.F., Wulff B.S., and Clausen J.T. Tissue-specific processing of cocaine- and amphetamine-regulated transcript peptides in the rat. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2722-2727
74. Vicentic A., Lakatos A., and Jones D. The CART receptors: background and recent advances. Peptides 27 (2006) 1934-1937
75. Vicentic A., and Jones D.C. The CART (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction. J. Pharmacol. Exp. Ther. 320 (2007) 499-506
76. Vrang N., Larsen P.J., Clausen J.T., and Kristensen P. Neurochemical characterization of hypothalamic cocaine-amphetamine-regulated transcript neurons. J. Neurosci. 19 (1999) 1-8
77. Vrang N. Anatomy of hypothalamic CART neurons. Peptides 27 (2006) 1970-1980
78. Wittmann G., Liposits Z., Lechan R.M., and Fekete C. Origin of cocaine- and amphetamine-regulated transcript-containing axons innervating hypophysiotropic corticotropin-releasing hormone-synthesizing neurons in the rat. Endocrinology 146 (2005) 2985-2991
79. Wynne W., Stanley S., McGowan B., and Bloom S. Appetite control. J. Endocrinol. 184 (2005) 291-318
80. Yermolaieva O., Chen J., Couceyro P.R., and Hoshi T. Cocaine- and amphetamine-regulated transcript peptide modulation of voltage gated Ca2+ signaling in hippocampal neurons. J. Neurosci. 21 (2001) 7474-7480
81. Zhang H., and Pandey S.C. Effects of PKA modulation on the expression of neuropeptide Y in rat amygdaloid structures during ethanol withdrawal. Peptides 24 (2003) 1397-1402
82. Zhou Y., Franck J., Spangler R., Maggos C.E., Ho A., and Kreek M.J. Reduced hypothalamic POMC and anterior pituitary CRF1 receptor mRNA levels after acute, but not chronic, daily "binge" intragastric alcohol administration. Alcohol. Clin. Exp. Res. 24 (2000) 1575-1582